Which hedge funds own ZNTL? ZENTALIS PHARMACEUTICALS INC, Q2 2026 13F holders
26 tracked hedge funds disclosed a position in ZNTL (ZENTALIS PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $120.6m in total. The largest holder by portfolio weight is 5AM Venture Management, LLC at 6.7% of its book. 6 opened a new position this quarter: Verdad Advisers, LP, Soleus Capital Management, L.P., Orbimed Advisors LLC, Spark Investment Management LLC. 11 exited: Almitas Capital LLC, CTC Alternative Strategies, Ltd., Birchview Capital, LP.
- 26
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 6
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 11
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $12.0m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $2.9m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $121m
- Combined value Sum of the holders' reported positions in the security.
- 2.1%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Almitas Capital LLC | 0.3% | $1.4m |
| CTC Alternative Strategies, Ltd. | 0.07% | $29.3k |
| Birchview Capital, LP | 0.02% | $41.0k |
| Catalyst Funds Management Pty Ltd | 0.01% | $39.1k |
| Woodline Partners LP | 0.0% | $623k |
| Hudson Bay Capital Management LP | 0.0% | $274k |
| Brevan Howard Capital Management LP | 0.0% | $110k |
| Tudor Investment Corp ET AL | 0.0% | $81.5k |
| Schonfeld Strategic Advisors LLC | 0.0% | $48.2k |
| Point72 Asset Management, L.P. | 0.0% | $222k |
| AQR Capital Management LLC | 0.0% | $53.1k |
Ownership over time
Who discovered ZNTL first? Beta
The run: Q2 2025 → Q2 2026, +318%
| Almitas Capital LLC | Q3 2024 | 0.5% | −0.7 pts |
| Matrix Capital Management Company, LP high conviction | Q3 2024 | 7.3% | −6.4 pts |
| Tybourne Capital Management (HK) Ltd high conviction | Q1 2025 | 5.0% | −8.0 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.